The process of family management when a baby is diagnosed with a lethal congenital condition

Gwen R Rempel1, Catriona Blythe, Laura G Rogers

  • 1University of Alberta, Edmonton, Alberta, Canada. gwen.rempel@ualberta.ca

Insights

The Family Management Style Framework (FMSF) helps parents manage infant illness. Key dimensions like Illness View and Child Identity are crucial for managing complex neonatal conditions.

Area of Science:

  • Pediatric Medicine
  • Family Studies
  • Psychology

Background:

  • Parental adaptation to infant's lethal congenital condition presents unique challenges.
  • Understanding family management processes is vital for effective support.
  • Previous research focused on chronic conditions, necessitating adaptation for lethal diagnoses.

Purpose of the Study:

  • To analyze family management styles in infants with lethal congenital conditions.
  • To apply the Family Management Style Framework (FMSF) to secondary data.
  • To identify key dimensions influencing parental management of infant illness.

Main Methods:

  • Secondary data analysis of 55 interviews with parents of infants with lethal congenital conditions.
  • Directed content analysis guided by a coding structure from family management dimensions.
  • Utilized the Family Management Style Framework (FMSF) as a conceptual basis.

Main Results:

  • The FMSF effectively differentiated family management processes from illness onset through post-surgery.
  • Illness View and Child Identity dimensions were central to parents' management capacity.
  • The framework provided insights into family adaptation during critical neonatal periods.

Conclusions:

  • The FMSF is a valuable tool for understanding family management of lethal congenital conditions.
  • Illness View and Child Identity are critical parental perspectives in managing infant illness.
  • Findings offer direction for clinical interventions and evaluation in neonatal care.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...